ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Novel COVID-19 vaccine shows promise in Canadian trial
July 05, 2021Phase I data shows VBI-2902a induced neutralisation and antibody titres up to five times that of people who had recovered from COVID-19 infection. -
CEPI and VBI to develop vaccines against SARS-CoV-2 variants
March 12, 2021The Coalition for Epidemic Preparedness Innovations (CEPI) and VBI Vaccines have entered a collaboration to advance the latter’s enveloped virus-like particle (eVLP) vaccine candidates against SARS-CoV-2 variants. -
VBI Vaccines begins enrolment in Covid-19 vaccine candidate study
March 11, 2021VBI Vaccines has commenced enrolment in an adaptive Phase I/II clinical study of its enveloped virus-like particle (eVLP) Covid-19 vaccine candidate, VBI-2902.
Pharma Sources Insight January 2025
